Zylox-Tonbridge Medical Technology Co., Ltd. Class H (HK:2190) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Zylox-Tonbridge Medical Technology Co., Ltd. announced that all resolutions presented at the 2023 Annual General Meeting were unanimously approved by attending shareholders. Significant outcomes included the adoption of the 2023 Board report, financial auditing report, and profit distribution plan, as well as the re-appointment of PricewaterhouseCoopers as the external auditor for 2024. Notably, a notable majority supported the re-election of Dr. Jonathon Zhong Zhao as an executive Director.
For further insights into HK:2190 stock, check out TipRanks’ Stock Analysis page.
